EU Matchmaking Event: Development and production of COVID-19 therapeutics

The European Commission’s Task Force for Industrial Scale-Up of COVID19 Vaccines and Therapeutics is organising an EU matchmaking event on COVID-19 therapeutics on 12th and 13th July 2021. Medicines for COVID-19 are still in the development phase. Therefore, the objective of the event is to help accelerate the development of new and repurposed medicines for COVID-19 therapeutics, i.e. medicines specifically developed for an indication in treatment of COVID-19, at all stages of COVID-19 disease and mobilise the EU pharma manufacturing capacity for their potential production.

The European Clusters Alliance, the Council of European BioRegions, and the European Cluster Collaboration Platform are collaborating with the European Commission on this event.

The target group is the entire EU COVID-19 therapeutics value chain starting with researchers and developers, through manufacturing companies and representatives of the hospitals, who apply such therapeutics to their patients. The providers of ancillary functions such as clinical trials services, accessories suppliers (e.g. vials, syringes, tubes etc.), funding providers and public procurers will also be targeted to take part in the event.

Interested organisations can now submit their expression of interest to participate: Register until 25th June 2021

Please find the eligibility criteria here: Call for Expression of Interest